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In Albright hereditary osteodystrophy, a monogenic
obesity disorder linked to heterozygous mutations
of Gsa, the G protein that mediates receptor-stimu-
lated cAMP generation, obesity develops only when
the mutation is on the maternal allele. Likewise,
mice with maternal (but not paternal) germline Gsa
mutation developobesity, insulin resistance, anddia-
betes. These parent-of-origin effects are due to Gsa
imprinting, with preferential expression from the ma-
ternal allele in some tissues. As Gsa is ubiquitously
expressed, the tissue involved in this metabolic
imprinting effect is unknown. Using brain-specific
Gsa knockout mice, we show that Gsa imprinting
within the central nervous system underlies these
effects and that Gsa is imprinted in the paraventricu-
lar nucleus of the hypothalamus. Maternal Gsamuta-
tion impaired melanocortin stimulation of energy
expenditure but did not affect melanocortin’s effect
on food intake, suggesting that melanocortins may
regulate energy balance in the central nervous
system through both Gsa-dependent and -indepen-
dent pathways.
INTRODUCTION
Monogenic obesity syndromes provide important clues about
genes that contribute to more common forms of obesity and
diabetes and the mechanisms by which these genes regulate
energy and glucose metabolism. One such disorder is Albright
hereditary osteodystrophy (AHO), which is caused by heterozy-
gous loss-of-function mutations of the G protein a subunit Gsa,
which mediates receptor-stimulated cAMP generation. While
any AHO patient may develop short stature or skeletal or neuro-
cognitive defects, only those with mutations on the maternal
allele develop multihormone resistance and obesity (Long548 Cell Metabolism 9, 548–555, June 3, 2009 ª2009 Elsevier Inc.et al., 2007). Likewise, mice with disruption of the maternal (but
not paternal) Gsa allele develop obesity, insulin resistance, and
diabetes associated with reduced sympathetic nervous system
(SNS) activity and energy expenditure (Chen et al., 2005a; Ger-
main-Lee et al., 2005; Xie et al., 2008). These parent-of-origin
metabolic effects are due to the fact that the Gsa gene GNAS
is affected by genomic imprinting, an epigenetic phenomenon
leading to Gsa being preferentially expressed from the maternal
allele in a small number of tissues (Weinstein et al., 2007). GNAS
also generates other gene products, but loss of these gene pro-
ducts does not lead to the metabolic phenotype seen in Gsa-
deficient mice (Weinstein et al., 2007).
The tissue involved in the parent-of-origin metabolic effects of
Gsa mutation is unknown. Liver, adipose tissue, and muscle are
not likely candidates, as Gsa expression is not affected by
imprinting in these tissues (Chen et al., 2005a; Germain-Lee
et al., 2005; Mantovani et al., 2004; Weinstein et al., 2007; Yu
et al., 2000). One potential site that could be involved is the
central nervous system (CNS), as the CNS is critical for regula-
tion of energy and glucose metabolism. Melanocortins act in
the CNS via receptors (MC4R, MC3R) that activate Gsa and
promote negative energy balance by decreasing food intake
and increasing SNS activity and energy expenditure (Brito
et al., 2007; Butler and Cone, 2002; Nogueiras et al., 2007).
MC4Rmutations lead to obesity in bothmice and humans (Butler
andCone, 2002; Farooqi et al., 2003; Huszar et al., 1997), and the
acute effects of melanotan II (MTII), an MC3R/MC4R agonist, on
food intake and energy expenditure are mediated primarily via
MC4R (Balthasar et al., 2005; Chen et al., 2000; Marsh et al.,
1999). MC4R pathways also regulate glucose metabolism and
insulin sensitivity (Fan et al., 2000; Nogueiras et al., 2007; Obici
et al., 2001). In contrast, MC3R mutation has no effect on food
intake and leads to a milder increase in adiposity (Butler and
Cone, 2002).
To determine whether Gsa imprinting in the CNS accounts for
these metabolic effects, we generated mice with CNS-specific
disruption of the maternal (mBrGsKO) or paternal (pBrGsKO)
Gsa allele and studied the effects on energy and glucose meta-
bolism and melanocortin regulation of food intake and energy
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Central Nervous System Imprinting of GsaFigure 1. Obesity in mBrGsKO, but Not pBrGsKO, Mice
(A) Body weights at given ages of female (left) and male (right) mBrGsKO (upper) and pBrGsKO mice (lower) and their respective controls. (Open bars, mutants;
closed bars, controls; n = 4–12).
(B) Body length of male mBrGsKO (left) and pBrGsKO (right) mice and their respective controls (n = 5–8).
(C and D) Total body weight, fat, and lean mass (in g) of 3.5- to 4.5-month-old male mBrGKO (left, n = 6) and pBrGsKO (right, n = 5) mice (C), female mBrGsKO
mice (n = 8) (D), and controls (n = 4–7).
(E) Interscapular BAT and gonadal (Gonad), retroperitoneal (Ret), and inguinal (Ing) fat pad weights in 8- to 10-month-old female mice (n = 4).
*p < 0.05 versus controls; mean ± SEM.expenditure. In addition, we examined several CNS regions that
are involved in metabolic regulation for evidence of Gsa
imprinting.
RESULTS
CNS-Specific Disruption of the Maternal Gsa Allele
Leads to Obesity
mBrGsKO and pBrGsKO mice were generated by reciprocal
crosses of Nestin-cre mice (which express cre recombinase in
the CNS) (Tronche et al., 1999), with mice hetero- or homozy-
gous for Gsa-flox (Chen et al., 2005b). The number of mutants
alive at weaning was consistent with expected Mendelian ratios.
Gsa expression was partially reduced in cerebral cortex and
cerebellum of mBrGsKO and pBrGsKOmice but was unaffected
in liver, brown adipose tissue [BAT], andmuscle (Figure S1 avail-
able online). mBrGsKO mice gained much more weight than
controls (Nestin-cre or Gsa-flox
) after 6 weeks (Figure 1A).
This was not associated with increased body length
(Figure 1B) but, rather, a significant increase in fat mass and
fat pad weights (Figures 1C, 1D, and 1E). In contrast, pBrGsKO
showed no differences in body weight or composition. Consis-tent with these changes, serum leptin levels were 4-fold higher
in mBrGsKO mice than in controls and were unaffected in
pBrGsKO mice (Table S1). The mBrGsKO phenotype was not
due to maternal gestational effects, as their mothers were Nes-
tin-cre and had normal Gsa expression (Chen et al., 2005b)
and metabolic phenotype. There were no differences in thyro-
tropin (TSH), thyroxine (T4), or triiodothyronine (T3) levels
between groups (Table S1).
Reduced Energy Expenditure in mBrGsKO Mice
Food intake at 6, 8, and 12 weeks in mBrGsKO mice and at
12 weeks in pBrGsKOmice was similar to controls when normal-
ized to body weight (Figures 2A and S2A). Absolute food intake
(kcal/d) was not increased in 6-week-old mBrGsKO mice even
though their body weight was already significantly increased
(Figures 2B and S2A). In contrast, MC4R knockout (MC4RKO)
and Agouti yellow mice have clearly increased food intake at
an early age before the development of obesity (Kublaoui
et al., 2006b; Weide et al., 2003). Body weight versus food intake
plot of individual mice showed a similar relationship between
these parameters in mBrGsKO and control mice (Figure S3A).
Once obesity was clearly established, mBrGsKO mice ateCell Metabolism 9, 548–555, June 3, 2009 ª2009 Elsevier Inc. 549
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Central Nervous System Imprinting of GsaFigure 2. Energy Metabolism in mBrGsKO and pBrGsKO Mice
(A) Food intake of 12-week-old male mBrGsKO (left; open bars, n = 6; closed bars, controls, n = 8) and pBrGsKO (right; open bars, n = 4; closed bars, controls,
n = 4) normalized to body weight (kcal/g0.75/d).
(B) Body weight (left) and absolute food intake (in kcal/d, right) of 5- to 6-week-old male mBrGsKO (n = 13) and control mice (n = 8).
(C) Feeding efficiency (weight gain/kcal intake) measured from weeks 6–8 in male mBrGsKO (n = 3) and control mice (n = 6).
(D) REE and TEE at 23C and 30C in 5-month-old male mBrGsKO (left, n = 6) and pBrGsKO (right, n = 5; controls, n = 4).
(E) REE and TEE at 21C in 5-month-old female mBrGsKO (n = 9) and controls (n = 8).
(F and G) Total and ambulatory (Amb) motor activity during experiments in (D) and (E), respectively.
(H) Increase in REE at 30C after administration of MTII (10 mg/g i.p.) in 4- to 5-month-oldmBrGsKO (left) and pBrGsKOmice (right) and controls (n = 6;% increase
versus after PBS).
(I) Resting O2 consumption at 21
C in 5-month-old femalemBrGsKO and control mice after 4 days of regular (RD, closed bars) or high-fat diet (HFD, hatched bars)
(n = 8–9).
(J) Food intake in 4- to 5-month-old mice after MTII (200 mg i.p.) (n = 5; % ingested versus after PBS).
*p < 0.05 versus controls; #p < 0.05 versus control on RD; mean ± SEM.more than controls did in order to maintain their higher body
weight (Figure S2A), which may be due to the development of
secondary leptin resistance in response to obesity, as seen in
MC4RKOmice (Marsh et al., 1999).We cannot rule out the possi-
bility thatmBrGsKOmice also have a primary abnormality in food
intake that occurs at a later age. However, increased food intake
is unlikely to account for the initial onset of obesity, as feeding
efficiency (weight gain/kcal intake) was more than 2-fold higher
in mBrGsKO mice when measured between 6 and 8 weeks
(Figure 2C).
Resting and total energy expenditure (REE and TEE, normal-
ized to body weight) were reduced in mBrGsKOmice at ambient550 Cell Metabolism 9, 548–555, June 3, 2009 ª2009 Elsevier Inc.temperatures (21C or 23C) but were normal at thermoneutral
temperature (30C) (Figures 2D and 2E). When not normalizing
for body weight, females had no increase in TEE at 21C even
though they had amuch greater bodyweight (Figure S2B). Males
had a small increase in TEE, and their body weights were much
higher. In both sexes, linear regressions of body weight versus
TEE showed themutants to follow a line significantly right shifted
compared to controls (Figures S3B and S3C). mBrGsKO mice
also had low total activity levels and low ambulating activity in
males at 23C (Figures 2F and 2G). In contrast, energy expendi-
ture and activity levels were unaffected in pBrGsKO mice. There
were no differences in respiratory exchange ratio (vCO2/vO2)
Cell Metabolism
Central Nervous System Imprinting of Gsabetween groups (data not shown). Therefore, similar to germline
Gsa knockout mice (Chen et al., 2005a; Yu et al., 2000), CNS-
specific disruption of the maternal (but not paternal) Gsa allele
led to obesity primarily due to an effect on energy expenditure.
Impaired Melanocortin Stimulation
of Energy Expenditure in mBrGsKO Mice
As MC4RKO mice have a similar phenotype to mBrGsKO mice,
we examined the acute change in energy expenditure in
response to the melanocortin agonist MTII in mBrGsKO mice.
REE at 30C was measured in the same animals on separate
days for 3 hr after i.p. injection of either MTII or PBS vehicle.
MTII stimulation of REE was markedly reduced in mBrGsKO
mice, whereas pBrGsKO mice responded similarly to controls
(Figure 2H). Diet-induced thermogenesis, which requires intact
MC4R pathways (Butler et al., 2001; Voss-Andreae et al.,
2007), was also impaired in mBrGsKOmice, as they failed, unlike
controls, to increase their REE after 4 days of high-fat diet
(Figure 2I). Germline maternal Gsa mutations lead to lower SNS
activity in both AHO patients (Carel et al., 1999) and mice (Xie
et al., 2008; Yu et al., 2000). Similarly, we found evidence of lower
SNS activity in mBrGsKO mice, with significantly reduced levels
of norepinephrine (NE) and its metabolite dihydroxyphenylglycol
(DHPG) (Figures S4A and S4B) in BAT tissue. Consistent with
reduced SNS stimulation, mBrGsKO mice had significantly
reduced Ucp1 (uncoupling protein 1) gene expression in BAT
(Figure S4C). Moreover, mBrGsKO mice had reduced heart
rate and diastolic blood pressure despite being severely obese
(Figures S4D and S4E).
Melanocortin Inhibition of Food Intake Is Unaffected
in mBrGsKO Mice
Food intake was measured in the same animals on separate
days for 3.5 hr at the beginning of the dark cycle after i.p. injec-
tion of either MTII or PBS vehicle. MTII reduced food intake in
both mBrGsKO and pBrGsKO mice to a similar extent as in
controls (Figure 2J), indicating no effect on the acute anorectic
effect of melanocortins. Similar results were also observed in
mice with maternal and paternal Gsa germline mutations (E1
m
and E1p, respectively) (Chen et al., 2005a; Xie et al., 2008)
(Figure S5). Overall, our findings indicate that mBrGsKO mice
have impaired stimulation of SNS activity and energy expendi-
ture by melanocortins, with no effect on food intake inhibition.
mBrGsKO, but Not pBrGsKO, Mice Develop Insulin
Resistance and Diabetes
BrGsKO mice also showed a similar imprinting effect on other
metabolic parameters that were observed in germline Gsa
knockout mice (Chen et al., 2005a). At 12 weeks, mBrGsKO
mice had markedly elevated serum glucose and insulin levels
and tended to have higher triglyceride levels, whereas these
were all unaffected in pBrGsKO mice (Table S1). Glucose and
insulin tolerance tests showed mBrGsKO, but not pBrGsKO,
mice to be severely glucose intolerant and insulin resistant
(Figures 3A and 3B). There were no differences in serum-free
fatty acids or corticosterone between the groups (Table S1).
To determine the extent to which abnormal glucose metabo-
lism inmBrGsKOmicewas independent of obesity, we assessed
glucose homeostasis in 5- to 6-week-old female mBrGsKOmicewith similar body weights as those of controls (Figure 3E). At this
age, glucose levels were unaffected (Figure 3C). Fasting insulin
levels (time 0 of GTT, Figure 3H) tended to be higher in the
mutants, whereas fed insulin levels were significantly higher in
mBrGsKO (Figure 3D). Even in the absence of obesity, young
mBrGsKO were glucose intolerant, with significantly higher
insulin levels at 120 min (Figures 3F and 3H), and had a tendency
toward insulin resistance (Figure 3G). These results suggest that,
similar to CNS melanocortin signaling (Fan et al., 2000; Noguei-
ras et al., 2007; Obici et al., 2001), CNS Gsa signaling directly
regulates peripheral glucosemetabolism and insulin action inde-
pendent of its effects on energy balance.
Gsa Is Imprinted in the Paraventricular Nucleus
of the Hypothalamus
In order to establish whether and where Gsa is imprinted in the
CNS, we performed in situ hybridization on brain sections with
a Gsa-specific probe. In regions with Gsa imprinting, maternal
mutation should lead to very low Gsa expression levels, whereas
paternal mutation should have less effect. In regions without Gsa
imprinting, both maternal and paternal mutations should lead to
a similar (50%) reduction in Gsa expression. We found that Gsa
mRNA levels in the paraventricular nucleus of the hypothalamus
(PVN) were markedly reduced in E1m mice compared to
controls, with only modest reductions in E1p mice (Figures 4A
and 4B). Similar findings were also observed in BrGsKO mice
(data not shown). Immunohistochemistry showed similar relative
changes in PVN Gsa protein expression (Figure S6). These
results indicate that Gsa undergoes imprinting in the PVN,
a region known to be important for metabolic regulation with
many MC4R-expressing neurons (Song et al., 2005; Voss-
Andreae et al., 2007). Gsa expression in PVN was unaffected in
leptin-deficient ob/obmice with severe obesity and insulin resis-
tance, ruling out that the reduced Gsa expression in E1
m mice
was secondary to its metabolic state (Figure 4A). However,
Gsa is not globally imprinted in the CNS, as Gsa expression in
the hippocampus and the nucleus of the solitary tract (NTS)
was similarly reduced by 50%–60% in both in E1m and E1p
mice (Figures 4A and 4B).
DISCUSSION
The present study is a nice example of how amonogenic obesity
disorder such as AHO can provide important insights into
the complex mechanisms involved in CNS regulation of energy
and glucose metabolism. The most common such disorder
that has been defined is that associated with MC4R mutations
(Farooqi et al., 2003). Here, we show that, similar to MC4Rmuta-
tions, CNS-specific disruption of Gsa is sufficient to produce
severe obesity, peripheral insulin resistance, and diabetes.
However, the effect of CNS-specific Gsa mutation is unique
and differs from MC4R receptor mutations in two important
respects. First, whereas MC4R mutation and models with
reduced melanocortin signaling develop hyperphagia early on
before the development of obesity (Kublaoui et al., 2006b;Weide
et al., 2003), CNS-specific Gsa mutation leads to a specific
defect in energy expenditure with little or no primary effect on
food intake before obesity is well established. Second, GsaCell Metabolism 9, 548–555, June 3, 2009 ª2009 Elsevier Inc. 551
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Central Nervous System Imprinting of GsaFigure 3. Glucose Metabolism in mBrGsKO and pBrGsKO Mice
(A and B) Glucose tolerance (n = 5–8/group; mBrGsKO p < 0.01 versus control and pBrGsKO p > 0.05 versus control by repeated-measures ANOVA) (A) and
insulin tolerance tests (n = 6–10; mBrGsKO p < 0.01 versus control and pBrGsKO p > 0.05 versus control by repeated-measures ANOVA) (B) in 12-week-old
male mBrGsKO (,, left), pBrGsKO (>, right), and control mice (-).
(C–G) Blood glucose (fasted and fed) (C), insulin levels (fed state; p < 0.05 versus control by unpaired t test) (D), body weight (E), glucose tolerance (mBrGsKO
p < 0.05 versus control by repeated-measures ANOVA) (F), and insulin tolerance (G) in young (6-week-old) female mBrGsKO (open bars) and control mice (closed
bars) (n = 8–12).
(H) Insulin levels at time 0 (fasted) and 120 min during the glucose tolerance test in (F).
*p < 0.05 versus controls by t test; mean ± SEM.mutation in the CNS has a parent-of-origin effect on metabolic
regulation due to tissue-specific imprinting in the CNS.
Our results are consistent with Gsa imprinting in the PVN,
which may be an important site for the imprinting effects of
Gsa mutation on energy and glucose metabolism in both AHO
patients and mice. Although disruption of other imprinted genes
such as Peg3 (paternally expressed 3) and Ndn (necdin) also
leads to hypothalamic dysfunction and obesity, unlike GNAS,
their gene products are expressed from the paternal rather
than maternal allele (Caqueret et al., 2005). We show no
evidence for Gsa imprinting in the brainstem NTS, another region
implicated in metabolic control by melanocortins (Ellacott and
Cone, 2004; Li et al., 2007), and therefore, this region is probably
not involved in the imprintedmetabolic phenotype. However, it is
possible that Gsa is also imprinted in other CNS sites outside of
the PVN where MC4R receptors are known to be expressed
(Kishi et al., 2003; Song et al., 2005; Voss-Andreae et al.,
2007). Gsa is also likely to be imprinted in specific brain regions
involved in cognitive function, as AHO patients with maternal
inheritance of Gsa mutations were found to have greater cogni-
tive impairment (Mouallem et al., 2008).
GNAS also generates an alternative neuroendocrine-specific
Gsa isoform (XLas) that is oppositely imprinted from Gsa, being552 Cell Metabolism 9, 548–555, June 3, 2009 ª2009 Elsevier Inc.transcribed from the paternal allele. Results from XLas knockout
mice (Xie et al., 2006) show that XLas andGsawork in the CNS to
produce opposite effects on SNS activity and energy and
glucose metabolism in a pattern consistent with the kinship
theory of genomic imprinting, which predicts that maternal and
paternal genes inhibit and stimulate the accumulation of energy
resources, respectively (Haig, 2004).
mBrGsKO mice had some features associated with loss of
MC4R receptors (obesity, reduced SNS activity and energy
expenditure, insulin resistance) but lacked others (increased
food intake and linear growth) (Butler and Cone, 2002; Farooqi
et al., 2003; Huszar et al., 1997; Weide et al., 2003), suggesting
that MC4Rs may mediate their effects through both Gsa-depen-
dent and -independent pathways. Despite the fact that melano-
cortins mediate their anorectic response primarily via MC4R
signaling in the PVN (Balthasar et al., 2005; Chen et al., 2000;
Kublaoui et al., 2006a), mBrGsKO mice with very low PVN Gsa
levels had a normal anorectic response to a melanocortin
agonist. Therefore, MC4Rs may alter food intake via a Gsa-inde-
pendent pathway. However, one study showed that excess
melanocortin signaling in the NTS of rats resulted in anorexia (Li
et al., 2007), and therefore, it may be possible that the anorectic
effect ofmelanocortins inmBrGsKOmice is occurring in theNTS.
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intake, our results show Gsa is required for melanocortin stimu-
lation of SNS activity and energy expenditure. Although Baltha-
sar and colleagues showed that restoration of MC4R in PVN of
MC4RKO mice did not restore the ability of melanocortins to
stimulate energy expenditure (Balthasar et al., 2005), it is
possible that this response requires the presence of MC4R in
both PVN and one or more other CNS sites involved in energy
Figure 4. Evidence for Gsa Imprinting in
Hypothalamic PVN
(A) In situ hybridization with antisense Gsa-specific
probe in PVN, nucleus of the solitary tract (NTS,
white arrows), and hippocampus of wild-type
(WT), E1m, and E1p mice (dark field, upper
panels; hematoxylin and eosin [H&E], lower
panels). Sense indicates the result in a WT mouse
using sense Gsa probe. Results for PVN of an ob/
ob mouse are shown on the right.
(B) Quantitation of in situ hybridization studies for
WT (closed bars), E1m (open bars), and E1p
mice (gray bars) expressed as % WT (n = 5–17).
*p < 0.05 versus WT; #p < 0.05 versus E1m by
one-way ANOVA; mean ± SEM.
regulation (Kishi et al., 2003; Song et al.,
2005; Voss-Andreae et al., 2007). Loss
of MC3R signaling may also contribute
to the mBrGsKO metabolic phenotype,
althoughMC3RKOmice are less severely
affected than mBrGsKO or MC4RKO
mice (Butler and Cone, 2002). Loss of
Gsa-mediated signaling pathways other
than those of melanocortins (e.g., chole-
cystokinins, glucagon-like peptide 1) may
also contribute to the metabolic conse-
quencesofGsamutations.However, these
latter pathways primarily affect food intake
rather than energy expenditure.
EXPERIMENTAL PROCEDURES
Mice
Femalemicewith loxP sites surroundingGsa exon1
(E1fl/fl; E1fl/+) (Chen et al., 2005b) were mated with
nestin-cre males (Jackson Laboratory) (Tronche
et al., 1999) to generate mBrGsKO mice.
pBrGsKO mice were generated with reciprocal
crosses. Animals were maintained on a 12 hr
light/dark cycle (6 AM/6 PM) and standard diet
(NIH-07, 5% fat by weight). These studies were
approved by the NIDDK Animal Care and Use
Committee.
Food Intake, Body Composition,
and Metabolism
Body composition was measured with the Echo3-
in1 NMRanalyzer (EchoMedical). Food intake was
measured as previously described (Yu et al.,
2000). Indirect calorimetry was performed using
a four-chamber Oxymax system (Columbus
Instruments; 2.5 l chambers with wire mesh floors,
using 0.6 l/min flow rate, 90 s purge, and 60 s
measure; one mouse/chamber). Motor activities were determined by infrared
beam interruption (Opto-Varimex mini; Columbus). For diet-induced thermo-
genesis, we measured resting O2 consumption at 23
C in mice on standard
diet or after 4 days of high-fat diet (59.36% fat, 16.16% protein, and 24.48%
carbohydrate; Bio-Serv).
MTII Injections
Single-caged mice received MTII (200 mg i.p.) or vehicle (PBS, 100 ml i.p.)
30 min before lights out, and food intake was measured for 3.5 hr in theCell Metabolism 9, 548–555, June 3, 2009 ª2009 Elsevier Inc. 553
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vehicle on separate days, and REE was measured for 3 hr at 30C (Xie et al.,
2006).
Glucose and Insulin Tolerance Tests
For glucose and insulin tolerance tests, overnight-fasted mice were given i.p.
glucose (2 mg/g body weight) or insulin (Humulin, 0.75 mIU/g). Glucose was
measured from tail blood with a Glucometer Elite (Bayer). Insulin was
measured by RIA (Linco).
In Situ Hybridization
In situ hybridization of brain slices was performed as previously described
(Cheng et al., 2001) using 118 bp sense and antisense RNA probes for Gsa
exon 1 (coding nucleotides 5–122). After hybridization, slides were exposed
to NTB2 emulsion for 3 days and then counterstained with hematoxylin and
eosin. Signals were quantified with Image-Pro Plus software (Media Cyber-
netics).
Biochemical Assays
Serum insulin and leptin levels were measured using radioimmunoassay (RIA)
kits (Linco Research). Serum corticosterone was measured using an RIA kit
(ICN Pharmaceuticals). Serum TSHwasmeasured with an RIA kit (Amersham).
Serum T3 and T4 were measured with RIA kits (Siemens Healthcare Diagnos-
tics). Free fatty acids and triglycerides were measured using reagents
purchased from Roche and Thermo DNA, respectively. Serum glucose levels
were measured using a Glucometer Elite (Bayer).
Immunoblot Analysis
Tissue protein extracts were separated on 8% Tris-glycine gels, and blots
were simultaneously incubated with Gsa-specific (Simonds et al., 1989) and
a-tubulin antibodies (EMD Chemicals). Protein was visualized with fluores-
cence-conjugated anti-mouse and anti-rabbit second antibodies (LI-COR).
Measurement of Tissue NE and DHPG
Tissues were homogenized in four volumes of 0.4 N perchloride acid and then
spun at 13,000 rpm, 4C for 20 min. NE and DHPG content were quantified in
supernatant by reverse phase liquid chromatography (Eisenhofer et al., 1986)
and were normalized to total protein.
Blood Pressure and Heart Rate Measurements
Blood pressure and heart rate were measured by a BP-2000 Specimen plat-
form (Visitech).
Quantitative RT-PCR
Ucp1 gene expression levels in BAT were measured by quantitative RT-PCR
method as described (Chen et al., 2005b).
Immunohistochemistry
Frozen brain sections were fixed in 4% formaldehyde for 10 min and washed
and placed in 3% H2O2 for 10 min. After blocking in 10% normal goat serum,
sections were incubated with rabbit anti-Gsa antibody (Simonds et al., 1989)
overnight at 4C. Sections were then incubated with biotinylated sheep anti-
rabbit secondary antibody (Vector) in blocking solution containing 10% sheep
serum and 1%BSA in PBS for 30min at room temperature. The signal was de-
tected and amplified using the ABC peroxidasemethod (Vector) and visualized
with 3,30-diaminobenzidine. Sections were counterstained with methyl green.
Statistical Analysis
Groups were compared with unpaired t tests unless indicated; otherwise, they
were compared with repeated-measures ANOVA or one-way ANOVA with
Tukey’s posttest, with differences considered significant at p < 0.05.
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